Matches in Nanopublications for { ?s ?p "[Altered expression of BTG1 is a potential biomarker for carcinogenesis and progression of GC, particularly for proximal nondiffuse and diffuse GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[Altered expression of BTG1 is a potential biomarker for carcinogenesis and progression of GC, particularly for proximal nondiffuse and diffuse GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Altered expression of BTG1 is a potential biomarker for carcinogenesis and progression of GC, particularly for proximal nondiffuse and diffuse GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Altered expression of BTG1 is a potential biomarker for carcinogenesis and progression of GC, particularly for proximal nondiffuse and diffuse GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1246155.RAWHiDokdgGKnxnuQpYM2gArrHTDsCh4jB31OV_mea1m0130_assertion description "[Altered expression of BTG1 is a potential biomarker for carcinogenesis and progression of GC, particularly for proximal nondiffuse and diffuse GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246155.RAWHiDokdgGKnxnuQpYM2gArrHTDsCh4jB31OV_mea1m0130_provenance.
- NP1246156.RAndCiEOh5BW4Wxs6mDBimKcSLZu2QJqFh5X-nn1vvJfs130_assertion description "[Altered expression of BTG1 is a potential biomarker for carcinogenesis and progression of GC, particularly for proximal nondiffuse and diffuse GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246156.RAndCiEOh5BW4Wxs6mDBimKcSLZu2QJqFh5X-nn1vvJfs130_provenance.
- NP1246157.RA-llM22VSAB_FmY2rLzJblVZ4pKH2P2-rXJZDNq_5qz4130_assertion description "[Altered expression of BTG1 is a potential biomarker for carcinogenesis and progression of GC, particularly for proximal nondiffuse and diffuse GC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246157.RA-llM22VSAB_FmY2rLzJblVZ4pKH2P2-rXJZDNq_5qz4130_provenance.